Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines-Reference-Cited by-同舟云学术

Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines

Published:2012-06 Issue:5 Volume:23 Page:505-514
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Morimoto Yoshihito,Takeuchi Osamu,Takizawa Asako,Yoneyama Hiroshi,Asanuma Fumiki,Suzuki Yukio,Atsuda Koichiro,Yamada Yoshinori

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference35 articles.

1. Pancreatic Cancer Registry in Japan: 20 years of experience.;Matsuno;Pancreas,2004

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.;Burris;J Clin Oncol,1997

3. The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer.;Boeck;Future Oncol,2008

4. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators.;Shirasaka;Anticancer Drugs,1996

5. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.;Tatsumi;Jpn J Cancer Res,1987

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells;Cancer Chemotherapy and Pharmacology;2024-09-14

2. Combined chemotherapy based on bioactive black phosphorus for pancreatic cancer therapy;Journal of Controlled Release;2023-02

3. Simultaneous inhibition of Chk1 and Bcl-xL induces apoptosis in vitro and represses tumour growth in an in vivo xenograft model;Journal of Chemotherapy;2022-09-22

4. Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2;Molecular and Cellular Biochemistry;2020-06-21

5. Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1;Oncology Reports;2019-11-28